María José Carmena Sierra-rekin lankidetzan egindako argitalpenak (10)

1999

  1. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate

    Cellular Signalling, Vol. 11, Núm. 11, pp. 813-819

1997

  1. Ontogenic development of the adenylyl cyclase enzyme and the α(s), α(i1) and α(i2) G-protein regulatory subunits from rat prostate

    Cellular Signalling, Vol. 9, Núm. 6, pp. 451-456

1996

  1. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate

    Endocrinology, Vol. 137, Núm. 7, pp. 2815-2822

  2. Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP, and carbachol: Role in prostatic proliferation

    Annals of the New York Academy of Sciences

  3. PACAP-preferring receptors in human hyperplastic prostate

    Annals of the New York Academy of Sciences

1995

  1. Protein kinase C isozymes in prostatic epithelial cells from normal, diabetic and insulin-treated diabetic rats

    General Pharmacology, Vol. 26, Núm. 8, pp. 1673-1678

1994

  1. Neuropeptide Y inhibits vasoactive intestinal peptide-stimulated adenylyl cyclase in rat ventral prostate

    Neuropeptides, Vol. 27, Núm. 1, pp. 31-37

  2. Ontogeny of vasoactive intestinal peptide receptors in rat ventral prostate

    General Pharmacology, Vol. 25, Núm. 3, pp. 509-514

1992

  1. The effect of streptozotocin diabetes on the vasoactive intestinal peptide receptor/effector system in membranes from rat ventral prostate

    Endocrinology, Vol. 131, Núm. 4, pp. 1993-1998

1991

  1. Cholesterol modulation of membrane fluidity and VIP receptor/effector system in rat prostatic epithelial cells

    Regulatory Peptides, Vol. 33, Núm. 3, pp. 287-297